Physician profile
Son Ha Yu
NPI 1073705778
$4,080.01
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2020: $314 · 2021: $827 · 2022: $302 · 2023: $712 · 2024: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,447.48 | 2021-2024 | Venaseal, Endurant Iis |
| Medtronic Vascular, INC. | $801.78 | 2019-2020 | |
| Shockwave Medical, INC | $576.88 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $504.72 | 2019-2021 | |
| Silk Road Medical, INC. | $392.72 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lemaitre Vascular, INC. | $118.77 | 2022 | |
| Cardiovascular Systems INC. | $96.01 | 2021 | |
| Endologix LLC | $30.57 | 2023 | |
| Janssen Pharmaceuticals, INC | $29.61 | 2019 | |
| Boston Scientific Corporation | $27.90 | 2019-2020 | |
| Tactile Systems Technology INC | $27.86 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $25.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Ha Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.